Y-mAbs Therapeutics stunned investors when SERB Pharmaceuticals announced an all-cash bid to take the company private at $8.60 per share, valuing the deal at approximately ...

The latest Consumer Price Index (CPI) report for July has painted a mixed picture for inflation, with consumer prices rising, but not at the rate ...

As Palantir’s stock has climbed over 600% in the past year, its LTM EV/ Revenue multiple stands at 118x which demands scrutiny against concentration risks, ...

US stocks edged higher on Tuesday, driven by fresh inflation data and President Trump's announcement of his nominee for the Bureau of Labor Statistics. ...